Focus: Navidea is a public radiopharmaceutical company specializing in diagnostic imaging agents, primarily focused on oncology and neurology applications. The company operates as a mid-cap biotech with a diversified pipeline spanning multiple disease areas.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Navidea Biopharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead clinical asset with two Phase 3 indications representing the company's most advanced oncology program.
Help build intelligence for Navidea Biopharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Navidea Biopharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Phase 2/3 PET imaging agent targeting large neurodegenerative disease space with high unmet diagnostic need.
Phase 3 radiopharmaceutical for movement disorder imaging; positions company in neurology franchise.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo